30.08.2011 • NewsMerckMerck Millipore

Merck Millipore Acquiring Amnis

Merck Millipore has agreed to acquire Seattle-based Amnis Corporation. Amnis designs, manufactures and markets high speed cell imaging instrumentation. The technology is used in flow cytometry applications in academic, biotech and pharmaceutical cell analysis and research. Amnis has 40 employees and generated sales of $14 million (€10 million) in 2010.

The transaction is subject to regulatory approvals and closing is expected to take place in the fourth quarter of 2011. Terms of the transaction were not disclosed.

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read